• Wiley Online Library will be disrupted on 26 May from 10:00-12:00 BST (05:00-07:00 EDT) for essential maintenance

Chapter 12. Cardiac Stem Cells and Myocardial Regeneration

  1. Gregory Bock Organizer,
  2. Jamie Goode
  1. Bernardo Nadal-Ginard,
  2. Piero Anversa,
  3. Jan Kajstura,
  4. Annarosa Leri

Published Online: 7 OCT 2008

DOI: 10.1002/0470091452.ch12

Stem Cells: Nuclear Reprogramming and Therapeutic Applications: Novartis Foundation Symposium 265

Stem Cells: Nuclear Reprogramming and Therapeutic Applications: Novartis Foundation Symposium 265

How to Cite

Nadal-Ginard, B., Anversa, P., Kajstura, J. and Leri, A. (2008) Cardiac Stem Cells and Myocardial Regeneration, in Stem Cells: Nuclear Reprogramming and Therapeutic Applications: Novartis Foundation Symposium 265 (eds G. Bock and J. Goode), John Wiley & Sons, Ltd, Chichester, UK. doi: 10.1002/0470091452.ch12

Author Information

  1. Department of Medicine, Cardiovascular Research Institute, Vosburgh Pavilion, New York Medical College, Valhalla, NY 10595, USA

Publication History

  1. Published Online: 7 OCT 2008
  2. Published Print: 18 MAR 2005

Book Series:

  1. Novartis Foundation Symposia

Book Series Editors:

  1. Novartis Foundation

ISBN Information

Print ISBN: 9780470091432

Online ISBN: 9780470091456

SEARCH

Keywords:

  • cardiac stem cells (CSCs);
  • myocyte death;
  • myocyte regeneration;
  • cycling ventricular myocytes;
  • cardiac homeostasis;
  • ‘cardiospheres’;
  • enhanced green fluorescent protein (EGFP);
  • ischaemic tissue;
  • Hepatocyte growth factor (HGF);
  • insulin-like growth factor 1 (IGF-1)

Summary

Until recently, the accepted paradigm considered the adult mammalian heart a post-mitotic organ without intrinsic regenerative capacity where neither myocyte death nor new myocyte formation played any role in its homeostasis and could be safely ignored. We have recently identified in the adult mammalian myocardium a small cell population expressing surface antigens commonly associated with a variety of stem cells. These cells have the behaviour and potential of bona fide cardiac stem cells (CSCs): they are clonogenic, self-renewing and multipotent. Their presence has identified myocyte death and myocyte renewal as the two sides of the proverbial coin of cardiac homeostasis. Myocyte renewal depends on the differentiation of the CSCs into immature myocytes that divide two to four times before becoming terminally differentiated. Both in vivo and in vitro the progeny of a single CSC can generate the three major cell types of the myocardium: myocytes, smooth muscle and endothelial vascular cells. More interestingly, when directly injected or activated with growth factors in the post-ischaemic myocardium, these cells are able to reconstitute a functional ventricular wall. Thus, although in the adult heart most cardiac myocytes are permanently withdrawn from the cell cycle, the heart has an intrinsic regenerative potential and it is not a terminally differentiated organ.